Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia

Brain Pathology

Volumn 10, Issue 1, 2000, Pages 95-112

  Del Zoppo, Gregory ^a   Ginis, Irene ^b   Hallenbeck, John M ^b   Iadecola, Constantino ^c   Wang, Xinkang ^d   Feuerstein, Giora Z ^d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; CYTOKINE; EXCITATORY AMINO ACID; INTERLEUKIN 1BETA; ION CHANNEL; L SELECTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NEUROPROTECTION; PROTEIN EXPRESSION; REPERFUSION;

EID: 0033979993     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00247.x     Document Type: Conference Paper

References (164)

1. 3 during focal cerebral ischemia. J Cereb Blood Flow Metab 19:1038-1050
2. Aronowski J, Strong R, Grotta JC (1997) Reperfusion Injury: Demonstration of Brain Damage Produced by Reperfusion After Transient Focal Ischemia in Rats. J Cereb Blood Flow Metab 17:1048-1056
3. Arvin B, Neville LF, Barone FC, Feuerstein GZ (1996) The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 20(6):445-52.
4. Auge N, Escargueil-Blanc I, Lajoie-Mazenc I, Suc I, Andrieu-Abadie N, Pieraggi MT, Chatelut M, Thiers JC, Jaffrezou JP, Laurent G, Levade T, Negre-Salvayre A, Salvayre R (1998) Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J Biol Chem 273(21): 12893-900.
5. Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87: 13-20
6. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW (1994) Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14(2):846-856
7. Barnes DA, Houston M, Perez HD (1998) TNF-α and IL-1β cross-desensitization of astrocytes and astrocytoma cell lines. J Neuroimmunol 87(1-2):17-26.
8. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG Feuerstein GZ (1997) Tumour necrosis factor α. A mediator of focal Ischemic brain injury. Stroke 28: 1233-1244
9. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, Sarau HM, Clark RK, Griswold DE (1991): Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 29: 336-345
10. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ (1992) Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev 16: 219-233
11. Barone FC, White RF, Spera PA, Currie RW, Wang XK, Feuerstein GZ (1998) Ischemic preconditioning and brain tolerance: Temporal histologic and functional outcomes, protein synthesis requirement, and IL-1ra and early gene expression. Stroke 29: 1937-1951
12. Betz AL, Yanag GY, Davidson BL (1995) Attenuation of stroke in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15: 547-551
13. Botchkina GI, Geimonen E, Bilof ML, et al. (1999) Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med 5(6): 372-381.
14. Botchkina GI, Meistrell ME III, Botchkina IL, Tracey KJ (1997) Expression of TNF and TNF receptor (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3(11): 765-781.
15. Bowes MP, Ziviin JA, Rothlein R (1993) Monoclonal antibody to ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 119: 215-219
16. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Medicine 2: 788-794.
17. Burda J, Martin ME, Gottlieb M, Chavko M, Marsala J, Alcazar A, Pavon M, Fando JL, Salinas M (1998) The intraischemic and early reperfusion changes of protein synthesis in the rat brain. elF-2 alpha kinase activity and role of initiation factors elF-2 alpha and elF-4E. J Cereb Blood Flow Metab 18(1):59-66.
18. Buttini M, Appel K, Sauater A, Gebicke-Haerter P-J, Boddeke HWGM (1996) Expression of tumour necrosis factor alpha after focal cerebral ischemia in the rat. Neuroscience 71: 1-16
19. Buttini M, Boddeki H (1995) Peripheral lipopolysaccharide stimulations induces interleukin-1β mRNA in rat brain microglial cells. Neuroscience 65: 523-550
20. Carroll JE, Howard EF, Hess DC, Wakade CG, Chen Q, Cheng C (1998) Nuclear factor- kappa B activation during cerebral reperfusion: effect of attenuation with N-acetyl-cysteine treatment. Brain Res Mol Brain Res 56: 186-91
21. Chen H, Chopp M, Bodzin G (1992) Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat. Neurosci Res Commun 11: 93-99
22. Chen J, Simon R (1997) Ischemic tolerance in the brain. Neurology 48(2):306-11
23. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 16: 578-584
24. Chopp M, Zhang RI, Chen H, Li Y, Jiang N, Rusche RJ (1994) Post ischemic administration of an anti-MAC-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Stroke 25: 869-876
25. Clark RK, Lee EV, White RF, Jonak ZL, Feuerstein GZ, Barone FC (1994) Reperfusion following focal stroke hastens inflammation and resolution of ischemic injury. Brain Res Bull 35: 387-391
26. Clark WM, Madden KP, Rothlein R, Zivin JA (1991) Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 75: 623-627
27. Crow JP, Beckman JS (1995) Reactions between nitric oxide, superoxide and peroxynitrite: Footprints of perxynitrite in vivo. In: Nitric oxide. Biochemistry, Molecular Biology and Therapeutic Implications (L. Ignarro and F. Murad, eds), San Diego, Academic Press, pp 17-43.
28. D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15(11):7293-7300.
29. Darnay BG and Aggarwal BB (1997) Early events in TNF signaling: a story of associations and dissociations. J Leutoc Biol 61(5):559-566.
30. Dawson DA, Martin D, Hallenbeck JM (1996) Inhibition of tumour necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 218: 41-44
31. Degraba TJ (1998) The role of acute inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy. Neurology 51: S62-S68
32. del Zoppo GJ (1994) Microvascular changes during cerebral ischaemia and reperfusion. Cerebrovasc Brain Metab Rev 6:47-96
33. 1 integrin immunoreactivity on cerebral microvessels and astrocytes following focal cerebral ischemia/reperfusion. Cerebrovasc Dis 6:9
34. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang C-M (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276-1283
35. del Zoppo GJ, von Kummer R, Hamann GF (1998) Ischemic damage of brain microvessels: Inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 65: 1-9
36. Di Loreto S, Balestrino M, Pellegrini P, Berghella AM, Del Beato T, Di Marco F, Adorno D (1997) Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. Neuroimmunomodulation 4(4): 195-199.
37. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397
38. Dutka AJ, Kochanek PM, Hallenbeck JM (1989) Influence of graulocytopenia on canine cerebral ischemia induced by an embolism. Stroke 20: 390-395
39. Eng LF (1988) Regulation of glial intermediate filaments in astrogliosis. In: Biochemical Pathology of Astrocytes, Norenberg MD, Hertz L, Schousboe A (Ed.), Alan R. Liss, 79-90
40. Fan K, Young PR, Barone FC, Feuerstein GZ, Smith DH, Mcintosh TK (1996) Experimental traumatic brain injury induces differential expression of TNF-α mRNA in the CNS. Mol Brain Res 36: 287-291
41. Feuerstein GZ, Wang XK, Barone FC (1998) Inflammatory mediators of ischemic injury: Cytokine gene regulation in stroke. In: Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, Ginsberg MD, Bogousslavsky J (Ed.), Blackwell Science Inc, 507-531
42. Forster C, Clark HB, Ross ME, Iadecola C (1999) Inducible nitric oxide synthase expression in human cerebral infarcts [In Process Citation]. Acta Neuropathol (Berl) 97: 215-20
43. Garcia JH, Kamijyo Y (1974) Cerebral infarction: Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 33: 409-421
44. Garcia JH, Liu K-F, Ye Z-R (1997) Cytokines and reperfusion in ischemic stroke. Brain Pathol 7: 1151-1161
45. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ (1994) Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 144:188-199
46. Ginis I, Schweizer U, Brenner M, Liu J, Azzam N, Spatz M, Hallenbeck JM (1999) TNF-a pretreatment prevents subsequent activation of cultureed brain cells with TNF-a and hypoxia via ceramide. Am J Physiol 276 (Cell Physiol): C1171-1183
47. Giulian D, Chen J, Ingeman JE, George JK, Noponen M (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to the adult mammalian brain. J Neurosci 9: 4416-4429
48. Goldblum SE, Sun WL (1990) Tumour necrosis factor-alpha augments pulmonary arterial transendothelial albumen flux in vitro. Am J Physiol 285: L57-L67
49. Goodman JC, Robertson CS, Grossman RG, Narayan RK (1990) Elevation of tumour necrosis factor in head injury. J Neuroimmunol 30: 2-3
50. Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J Neurochem 66: 869-872.
51. Gosh S, Struim JC, Bell AM (1997) Lipid Biochemistry: Function of glycorolipids and sphingolipids in cellular singaling. FASEB J 11: 45-50.
52. Grandati M, Verrecchia C, Revaud ML, Allix M, Boulu RG, Plotkine M (1997) Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br J Pharmacol 122: 625-30
53. Griffith OW, Stuehr DJ (1995) Nitric oxide synthases: properties and catalytic mechanism. Ann Rev Physiol 57: 707-36
54. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF- kappaB activation. Science 274: 1383-5
55. Gross SS, Wolin MS (1995) Nitric oxide: pathophysiological mechanisms. Ann Rev Physiol 57: 737-69
56. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kummaroo KK, Thompson CB:, Obrenovitch TP, Contrersa TJ (1986) Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17: 246-253
57. Hallenbeck JM, Dutka AJ, Vogel SN, Heldman E, Doron DA, Feuerstein G (1991) Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain Res 541(1):115-120
58. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ (1995) Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26:2120-2126
59. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274(5294): 1855-1859.
60. Haring H-P, Akamine P, Habermann R, Koziol JA, del Zoppo GJ (1996) Distribution of the integrin-like immunoreactivity on primate brain microvasculature. J Neuropathol Exp Neurol 55: 236-245
61. Haring H-P, Berg EL, Tsurushita N, Tagaya M, del Zoppo GJ (1996) E-selectin appears in non-ischemic tissue during experimental focal cerebral ischemia. Stroke 27:1386-1392
62. Hayward NJ, Elliot PJ, Sawyer SD, Bronson RJ, Bartus RT (1996) Lack of evidence for neutrophil participation during infarct formation following focal cerebral ischemia in the rat. Exp Neurol 139: 188-202
63. Heidenreich KA, Kummer JL (1996) inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 271: 9891-9894
64. Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RF (1994) Leukocyte involvement in cerebral infarct generation after ischemia and repeerfusion. Brain Res Bull 34: 37-141
65. Heo J, Lucero J, Abumiya T, Koziol J, Copeland B, del Zoppo G (1999) Matrix metalloproteinases increase very early during experimental focal ischemia. J Cereb Blood Flow Metab 19:624-633
66. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16: 981-987
67. Huwiler A, Dorsch S, Briner VA, van den Bosch H, Pfeilschifter J (1999) Nitric oxide stimulates chronic ceramide formation in glomerular endothelial cells. Biochem Biophys Res Commun 258(1):60-65.
68. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain damage. Trends Neurosci 20: 132-138
69. Iadecola C, Forster C, Nogawa S, Clark HB, Ross ME (1999) Cyclooxygenase immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathologica 98: 9-14
70. Iadecola C, Salkowski CA, Zhang F, Aber T, Nagayama M, Vogel SN, Ross ME (1999) The Transcription Factor Interferon Regulatory Factor 1 Is Expressed after Cerebral Ischemia and Contributes to Ischemic Brain Injury. J Exp Med 189: 719-727
71. Iadecola C, Xu X, Zhang F, El-Fakahany EE, Ross ME (1995) Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab 14: 52-59
72. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME (1996) Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27: 1373-1380
73. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME (1997) Delayed reduction in ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17: 9157-9164
74. Iadecola C, Zhang F, Xu X (1995) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268: R286-R292
75. Iadecola C, Zhang F, Xu X, Casey R, Ross ME (1995c) Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15: 378-384
76. Ito A, Horigome K (1995) Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65(1):463-6.
77. Jiang N, Moyle M, Soule HR, Rote WE, Chopp M (1995) Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol 38: 935-942
78. Karsan A, Harlan JM (1996) Modulation of endothelial cell apoptosis: mechanisms and pathophysiological roles. J Atheroscler Thromb 3(2):75-80.
79. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93: 2317-2321
80. Khayyam N, Thavendiranathan P, Carmichael FJ, Kus B, Jay V, Burnham WM (1999) Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. Neuroreport 10: 371-4
81. Kobayashi E, Nakano H, Morimoto M, Tamaoki T (1990) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999
82. Kogure K, Yamasaki Y, Matsuo Y, Kato H, Onodera H (1996) Inflammation of the brain after ischemia. Acta Neurochir 66 (Suppl.): 40-43
83. Kontos CD, Wei EP, Williams JI, Kontos HA, Povlishock JT (1992) Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. Am J Physiol 263: H1234-1242
84. Lee JY, Leonhardt LG, Obeid LM (1998) Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem J 334 (Pt 2):457-61.
85. Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Production of tumour necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86: 6348-6352
86. Liu T, Ginis I, Spatz M, Hallenbeck JM (2000) Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and ceramide. Am J Physiol (Cell Physiol) in press
87. Liu T, Clark RK, Mcdonnell PC, Young PR, White RF, Barone FC, Feuerstein GF (1994) Tumour necrosis factor α expression in ischemic neurons. Stroke 25: 1481-1488
88. Liu T, McDonnel PC, Young PR, White RF, Siren AL, Barone FC, Feuerstein GZ (1993) Interleukin-1β mRNA expression in ischemic rat cortex. Stroke 24: 1746-1751
89. Loddick SA, Rothwell NJ (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal ischemia in the rat. J Cereb Blood Flow Metab 16: 932-940
90. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-50
91. Martin D, Chinookoswong N, Miller G (1995) The interleukin-1 receptor antagonist (rhlL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 130: 362-367
92. Matsuo Y, Onodera H, Shiga Y, Nakamur M, Ninomiya M, Kihara T, Kogure K (1994) Correlation between myeloperoxidose-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke 25: 1469-1475
93. Mattson M (1997) Neuroprotective signal transduction: Relevancte to stroke. Neurosci Biobehav Rev 21(2):193-206.
94. Melillo G, Taylor LS, Brooks A, Cox GW, Varesio L (1996) Regulation of inducible nitric oxide synthase expression in IFN-gamma- treated murine macrophages cultured under hypoxic conditions. J Immunol 157: 2638-44
95. Miettinen S, Fusco FR, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, Narhi M, Hokfelt T, Koistinaho J (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 94: 6500-5
96. Minami M, Kuraishi Y, Satoh M (1991) Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNF-α and LIF in the rat brain. Biochem Biophys Res Commun 176: 593-598
97. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M (1992) Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem 58: 390-392
98. Mori E (1991) Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism, in Hacke W, del Zoppo GJ, Hirschberg M (eds): Edition, Heidelberg, Springer-Verlag pp 137-146
99. Mori E, Chambers JD, Copeland BR, Arfors K-E, del Zoppo GJ (1992) Inhibition of polymorphonuclear leukocyte adherence suppresses non-reflow after focal cerebral ischemia. Stroke 23:712-718
100. Mori E, Zoppo M Del, Chambers GL, Copeland JD, Arfors KE (1992b) Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23: 712-718
101. Mori T, Asano T, Matsui T, Muramatsu H, Ueda M, Kamiya T, Katayama Y, Abe T (1999) Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res 816(2):350-7.
102. Nagayama M, Aber T, Nagayama T, Ross ME, Iadecola C (1999) Age-dependent increase in ischemic brain injury in wild-type mice and in mice lacking the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 19: 661-6
103. Nagayama M, Zhang F, Iadecola C (1998) Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab 18: 1107-13
104. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J, Graham SH (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 95: 10954-9
105. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100: 2417-23
106. Nawashiro H, Martin D, Hallenbeck JM (1997) Inhibition of tumour necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17: 229-232
107. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-alpha pre-treatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17(5):483-90.
108. Nguyen H, Hiscott J, Pitha PM (1997) The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 8: 293-312
109. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C (1998) Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95: 10966-71
110. Nogawa S, Zhang F, Ross ME, Iadecola C (1997) Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17: 2746-2755
111. Norton WT, Aquino DA, Hozumi I, Chiu TC, Brosnan CF (1992) Quantitative aspects of reactive gliosis: a review. Neurochem Res 17: 877-885
112. O'Callaghan JP (1991) Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 4: 197-206
113. 3 is expressed in selected microvessels following focal cerebral ischemia. Am J Pathol 149:37-44
114. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, Del Zoppa GZ (1994) P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25: 202-211
115. Parmentier S, Bohme GA, Lerouet D, Damour D, Stutzmann JM, Margaill I, Plotkine M (1999) Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol 127: 546-52
116. Pena LA, Fuks Z, Kolesnick R (1997) Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 53(5):615-21.
117. Perry VH, Gordon S (1991) Macrophages and the nervous system. Int Rev Cytol 125: 203-244
118. Pickard JD (1981) Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J. Cereb. Blood Flow Metabol 1: 361-384
119. Planas AM, Soriano MA, Rodriguez-Farre E, Ferrer I (1995) Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci Lett 200: 187-90
120. Relton JK, Martin D, Thompson RC, Russell DA (1996) Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Ex Neurol 138: 206-213
121. Bobbins DS, Shirazi Y, Drydale BE, Lieberman A, Shin HS, Shin ML (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139: 2593-2597
122. Romanic AM, White RF, Arleth AJ, Ohlstein EO, Barone FC (1998) Matrix metalloproteinase expression increases following cerebral focal ischemia: Inhibition of MMP-9 reduces infarct size. Stroke 29: 1020-1030
123. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG (1995) Tumour necrosis factor-α-induced gelatinase B causes delayed opening of the blood brain barrier: an expanded therapeutic window. Brain Res 703: 151-155
124. Rothwell NJ (1991) Functions and mechanism of interleukin-1 in the brain. Trends Pharmacol Sci 12: 430-435
125. Rothwell NJ, Relton JK (1993) Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovas Brain Metab Rev 5: 178-198
126. Salvemini D, Masferrer JL (1996) Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol 269: 12-25
127. Samdeni AF, Dawson TM, Dawson VL (1997) Nitric oxide synthase in models of focal ischemia. Stroke 28: 1283-1288
128. Sawada M, Kondo N, Suzumura A, Marunouchi T (1989) Production of tumour necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491: 394-397
129. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, Isakson P (1995) Mediation of inflammation by cyclooxygenase-2. Agents and Actions Suppl 46: 41-50
130. Semmler JH, Wachtel H, Endres S (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumour necrosis factor-α production by human mononuclear cells. Int J Immunopharm 15: 409-413
131. Shohami E, Bass E, Wallach D, Yamin A, Gallily R (1996) Inhibition of tumour necrosis factor alpha (TNF-α activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 16: 378-384
132. Shohami E, Ginis I, Hallenbeck JM (1999) Dual role of tumor necrosis factor alpha in brain injury. Cytokine and Growth Factor Reviews 10: 119-130
133. Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF-α and IL-6 by brain tissue. J Cereb Blood Flow Metab 14: 615-619
134. Siren AL, Heldman E, Doron D, Lysko PG, Yue T-L, Liu T, Feuerstein GZ, Hallenbeck J (1992) Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke 23: 1643-1651
135. Smith RA, Baglioni C (1992) Characterization of TNF receptors. Immunol Se 56: 149-160
136. Smith WL, DeWitt DL (1995) Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Sem Nephrol 15: 179-94
137. Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1-17
138. Smyth MJ, Obeid LM, Hannun YA (1997) Ceramide: a novel lipid mediator of apoptosis. Adv Pharmacol 41:133-54.
139. Subbaramaiah K, Chung WJ, Dannenberg AJ (1998) Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 273(49): 32943-9.
140. Suematsu M, Tsuchiya M (1992) Microtopographic analysis of oxidative stress in organ micro-vasculatory units. Adv Exp Med Biol 316: 211-221.
141. Tagaya M, Liu KF, Copeland B, Seiffert D, Engler R, Garcia JH, del Zoppo GJ (1997) DNA scission after focal brain ischemia. Temporal differences in two species. Stroke 28(6):1245-54
142. Tasaki K, Ruetzler CA, Ohtsuki Tu, Martin D, Nawashiro H, Hallenbeck JM (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748(1-2):267-70.
143. Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ (1997) CD95/Fast-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem 272(39):24308-12.
144. Tracy KJ, Ceraml A (1994) Tumour necrosis factor: A pleotropic cytokine and therapeutic target. Ann Rev Med 45: 491-503
145. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M (1997) Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 17(5):491-499.
146. Van Antwerp DJ, Martin SJ, Verma IM, Green DR (1998) Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol 8(3):107-11.
147. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C (1994) Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol 152(8):4110-8
148. Vourte J, Linsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H (1999) Anti-ICAM-1 monoclonal antibody R65 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 162: 2353-2357
149. 4 during focal cerebral ischemia/reperfusion. Stroke 28:858-865
150. Wang X-K, Barone FC, Aiyar NV, Feuerstein GZ (1997) Increased interleukin-1 receptor and interleukin-1 receptor antagonist gene expression after focal stroke. Stroke 28: 155-162
151. Wang X-K, Li X. Erhardt JA, Barone FC, Feuerstein GZ (2000) Detection of Tumor necrosis factor-α mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction. J Cereb blood Flow Metab, in press.
152. Wang X-K, Siren A-L, Yue T-L, Barone FC, Feuerstein GZ (1994) Upregulation of intracellular adhesion molecule-1 (ICAM1) on brain microvascular endothelial cells in rat ischemic cortex. Mol Brain Res 26: 61-68
153. Wang X-K, Yue T-L, Barone FC, Feuerstein GZ (1995) Demonstration of increased endothelial-leukocyte adhesion molecule 1 mRNA expression in rat ischemic cortex. Stroke 26: 1665-1669
154. Wang XK, Yue T-L, Barone FC, White R, Young PR, McDonnell PC, Feuerstein GZ (1994) Concomitant cortical expression of TNF-α and IL-1β mRNA following transient focal ischemia. Mol Chem Neuropathol 23: 103-114
155. Wang YM, Seibenhener ML, Vandenplas ML, Wooten MW (1999) Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival. J Neurosci Res 55(3):293-302.
156. Xia Z, Dickens M, Raingeaud J, Davis JR, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331
157. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, Choi DW, Hsu CY (1998) Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 27:16521-16526.
158. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-86
159. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain damage in the rats. Stroke 26: 676-681
160. Young AR, Touzani O, Derlon J-M, Sette G, MacKenzie ET, Baron J-C (1997) Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: A quantitative analysis of infarction volume. Stroke 28:632-638
161. Zhang RL, Chopp M, Jaing N, Tang WX, Prostak J, Manning AM, Anderson DC (1995) Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26:1438-1443
162. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, Jone M, Miyasaka M, Ward P (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44: 1747-1751
163. Zhang RL, Zhang ZG, Chopp M (1999) Increased therapeutic efficacy with rt-PA and anto-CD18 antibody treatment of stroke in the rat. Neurology 52: 273-279
164. Zhao X, Haensel C, Ross ME, Iadecola C (1999) Gene-dosing effect of reduction of ischemic brain injury in mice lacking the inducible nitric oxide synthase gene. Soc Neurosci Abstr 25 (part 1): 793